Policy Name Effective Date Updated Review Date
Hematology/Oncology
MP-038 Circulating Tumor DNA and Circulating Tumor Cells for Cancer Management (Liquid Biopsy) August 26, 2020 August 26, 2020 August 26, 2021
MP-042 Electric Tumor Treatment Field Therapy for the Treatment of Glioblastoma Multiforme May 20, 2020 May 20, 2020 May 20, 2021